Odonate's Oral Taxane Tesetaxel Shows PFS Benefit In Metastatic Breast Cancer Phase III

 
• By Jessica Merrill
  
Stepping stones
Odonate hopes tesetaxel is on the path to FDA approval • Source: Shutterstock

More from Clinical Trials

More from R&D